An Evaluation of the Costs and Benefits of the New Psychological Support Service for Patients On Long-Acting Injectable Buprenorphine

被引：0
|
作者：
Melichar, Jan [1 ,2 ,3 ,4 ]
James, Lucie [1 ,5 ]
Greenwood, Rosemary [6 ,7 ]
机构：
[1] Cardiff & Vale UHB, Cardiff, Wales
[2] Aneurin Bevan UHB, Newport, Wales
[3] Univ Bath, Bath, Avon, England
[4] Univ South Wales, Newport, Gwent, Wales
[5] Cardiff Univ, Cardiff, Wales
[6] UBHW, Bristol, Avon, England
[7] Univ Bristol, Bristol, Avon, England
来源：
BJPSYCH OPEN | 2024年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [1] An Evaluation of the Costs and Benefits of the New Psychological Support Service for Patients On Long-Acting Injectable Buprenorphine
    Melichar, Jan
    James, Lucie
    Greenwood, Rosemary
    BJPSYCH OPEN, 2024, 10 : S197 - S197
  • [2] Use of long-acting injectable buprenorphine in the correctional setting
    Martin, Rosemarie A.
    Berk, Justin
    Rich, Josiah D.
    Kang, Augustine
    Fritsche, John
    Clarke, Jennifer G.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 142
  • [3] EVALUATION OF A LONG-ACTING INJECTABLE OXYTETRACYCLINE
    CORNWELL, RL
    MODERN VETERINARY PRACTICE, 1980, 61 (11): : 945 - 947
  • [4] Risperidone long-acting injectable in patients with a new diagnosis of psychosis
    Parellada, E
    Chrzanowski, W
    Andrezina, R
    Milanova, V
    Glue, P
    Medori, R
    Masiak, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S75 - S76
  • [5] A retrospective review of patterns of use of long-acting injectable buprenorphine products
    Daglish, Mark R. C.
    Hayllar, Jeremy S.
    McDonough, Mike
    DRUG AND ALCOHOL REVIEW, 2022, 41 : S51 - S51
  • [6] TRACING THE AFFORDANCES OF LONG-ACTING INJECTABLE DEPOT BUPRENORPHINE: A QUALITATIVE STUDY OF PATIENTS' EXPERIENCES IN AUSTRALIA
    Barnett, Anthony
    Savic, Michael
    Lintzeris, Nicholas
    Bathish, Ramez
    Arunogiri, Shalini
    Dunlop, Adrian J.
    Haber, Paul S.
    Graham, Robert
    Hayes, Vicky
    Lubman, Dan I.
    DRUG AND ALCOHOL REVIEW, 2021, 40 : S18 - S18
  • [7] Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia
    Barnett, Anthony
    Savic, Michael
    Lintzeris, Nicholas
    Bathish, Ramez
    Arunogiri, Shalini
    Dunlop, Adrian J.
    Haber, Paul
    Graham, Robert
    Hayes, Vicky
    Lubman, Dan, I
    DRUG AND ALCOHOL DEPENDENCE, 2021, 227
  • [8] Patients' decisions to initiate long-acting injectable buprenorphine for opioid use disorder: Qualitative study
    Neale, Joanne
    Parkin, Stephen
    Strang, John
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S127 - S128
  • [9] LONG-ACTING INJECTABLE ANTIPSYCHOTICS: FROM PHARMACOKINETICS TO THE BENEFITS FOR THE PATIENT
    Fraguas, D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 5 - 6
  • [10] Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in Taiwan
    Chang, H.
    Su, K.
    McCropne, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S446 - S447
12345